TY - JOUR
T1 - Rat sinusoidal liver endothelial cells (SECs) produce pro-fibrotic factors in response to adducts formed from the metabolites of ethanol
AU - Thiele, Geoffrey Milton
AU - Duryee, Michael J.
AU - Freeman, Thomas L.
AU - Sorrell, Michael Floyd
AU - Willis, Monte S.
AU - Tuma, Dean J.
AU - Klassen, Lynell Warren
N1 - Funding Information:
We thank the members of the Experimental Immunology Laboratory at the Omaha VA Medical Center including, Karen C. Easterling, Carlos D. Hunter, and Bartlett C. Hamilton III for their valuable help with this project. Supported by: National Institutes of Health Grants: R01 AA10435 and R37 AA07818. Also supported by a Department of Veterans Affairs Merit Review and the Department of Veterans Affairs Alcohol Research Center at the Omaha VA Medical Center.
PY - 2005/11/25
Y1 - 2005/11/25
N2 - Previous studies with alcohol-associated malondialdehyde-acetaldehyde (MAA)-modified proteins have demonstrated an increase in the expression of adhesion molecules, and the secretion of pro-inflammatory cytokines/chemokines by rat sinusoidal liver endothelial cells (SECs). However, no studies have been initiated to examine the effects of MAA-modified proteins on the expression of the extracellular matrix (ECM) protein, fibronectin and its isoforms. For these studies, SECs were isolated from the liver of normal rats, and exposed to MAA-modified bovine serum albumin (MAA-Alb). At selected time points, the total plasma and cellular fibronectin were determined by Western blot. Injection of rat liver via the mesenteric vein with MAA-Alb was performed in an effort to evaluate the potential in vivo role of MAA-modified proteins in the development of fibrosis. Expression of both plasma and cellular fibronectin was significantly increased over controls in the MAA-Alb stimulated SECs (>3-fold). Importantly, the isotype of fibronectin secreted was determined to be of the EIIIA variant and not EIIIB. These data were confirmed using RT-PCR procedures on liver tissue from; isolated SECs, and from an in vivo animal model wherein MAA-Alb was administered via the mesenteric vein. Thus, these studies demonstrate that MAA-modified proteins initiate a pro-fibrogenic response by initiating the expression of the fibronectin EIIIA isoform by SECs.
AB - Previous studies with alcohol-associated malondialdehyde-acetaldehyde (MAA)-modified proteins have demonstrated an increase in the expression of adhesion molecules, and the secretion of pro-inflammatory cytokines/chemokines by rat sinusoidal liver endothelial cells (SECs). However, no studies have been initiated to examine the effects of MAA-modified proteins on the expression of the extracellular matrix (ECM) protein, fibronectin and its isoforms. For these studies, SECs were isolated from the liver of normal rats, and exposed to MAA-modified bovine serum albumin (MAA-Alb). At selected time points, the total plasma and cellular fibronectin were determined by Western blot. Injection of rat liver via the mesenteric vein with MAA-Alb was performed in an effort to evaluate the potential in vivo role of MAA-modified proteins in the development of fibrosis. Expression of both plasma and cellular fibronectin was significantly increased over controls in the MAA-Alb stimulated SECs (>3-fold). Importantly, the isotype of fibronectin secreted was determined to be of the EIIIA variant and not EIIIB. These data were confirmed using RT-PCR procedures on liver tissue from; isolated SECs, and from an in vivo animal model wherein MAA-Alb was administered via the mesenteric vein. Thus, these studies demonstrate that MAA-modified proteins initiate a pro-fibrogenic response by initiating the expression of the fibronectin EIIIA isoform by SECs.
KW - Adducts
KW - Alcohol
KW - Aldehydes
KW - Endothelial cells
KW - Extracellular matrix (ECM)
KW - Fibronectin
UR - http://www.scopus.com/inward/record.url?scp=27544447988&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27544447988&partnerID=8YFLogxK
U2 - 10.1016/j.bcp.2005.08.014
DO - 10.1016/j.bcp.2005.08.014
M3 - Article
C2 - 16202982
AN - SCOPUS:27544447988
SN - 0006-2952
VL - 70
SP - 1593
EP - 1600
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 11
ER -